Description of the FVH cohort. (A) Distribution of the viruses implicated in FVH in these FVH patients. (B) Sex distribution of the FVH patients according to the infecting virus. (C) Anti-HSV-1 IgG titers in the plasma of HSV-FVH patients, as determined by ELISA.